John Longshore, PhD, FACMG, discusses selecting between comprehensive vs single-gene molecular testing in lung cancer.
John W. Longshore, PhD, Carolinas Pathology Group
Advertisement
Articles by John W. Longshore, PhD, Carolinas Pathology Group
John Longshore, PhD, FACMG, discusses key molecular markers in metastatic lung cancer.
Advertisement
Latest Updated Articles
Dr. Longshore on Key Molecular Markers in Metastatic Lung CancerMarch 10th 2021
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts Third RP1 BLA Resubmission With Nivolumab in Advanced Melanoma
2
MAIC Shows OS Benefit With Mogamulizumab vs Vorinostat in Cutaneous T-Cell Lymphoma Subtypes
3
From "Not Curable" to "May Be Curable": Joshua Richter, MD, on the New Reality of Multiple Myeloma
4
Real-World Mogamulizumab Elicits Durable Responses in Pretreated Mycosis Fungoides and Sézary Syndrome
5